A stable, engineered TL1A ligand co-stimulates T cells via specific binding to DR3
Zwolak, Adam, Chan, Szeman Ruby, Harvilla, Paul, Mahady, Sally, Armstrong, Anthony A, Luistro, Leopoldo, Tamot, Ninkka, Yamada, Douglas, Derebe, Mehabaw, Pomerantz, Steven, Chiu, Mark, Ganesan, Rajkumar, Chowdhury, Partha
Published in Scientific reports (29.11.2022)
Published in Scientific reports (29.11.2022)
Get full text
Journal Article
Abstract 5567: In vivo administration of the STING agonist, JNJ-67544412, leads to complete regression of established murine subcutaneous tumors
Smith, Melissa, Chin, Diana, Chan, Szeman, Mahady, Sally, Campion, Liam, Morgan, Caitlin, Patel, Shefali, Chu, Gerald, Hughes, Anna, Bignan, Gilles, Connolly, Pete, Emanuel, Stuart, Packman, Kathryn, Luistro, Leopoldo L.
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article
Abstract 5567A: JNJ-‘6196: A next generation STING agonist with potent preclinical activity by the IV route
Chan, Szeman Ruby, Bignan, Gilles, Pierson, Emily, Mahady, Sally, Ta, Hayley, Schepens, Wim, Thuring, Jan Willem, Lim, Heng Keang, Otieno, Monicah, Wilde, Thomas, Singer, Monica, Bogdan, Nancy, Patel, Shefali, Luistro, Leo, Campion, Liam, Smith, Melissa, Wiley, Diana, Packman, Kathryn, Allegrezza, Michael, Morgan, Caitlin, Sendecki, Jocelyn, Van Aller, Glenn, Krosky, Daniel, Connolly, Peter, Edwards, James, Staquet, Kim, Emanuel, Stuart L.
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article